Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?

× No keyword cloud information.

8 in total

1. Segmented regression analysis of interrupted time series studies in medication use research.

Authors: A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal: J Clin Pharm Ther Date: 2002-08 Impact factor: 2.512

2. Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit.

Authors: T S Jacoby; R S Kuchenbecker; R P Dos Santos; L Magedanz; P Guzatto; L B Moreira
Journal: J Hosp Infect Date: 2010-03-24 Impact factor: 3.926

3. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies.

Authors: Michelle Shardell; Anthony D Harris; Samer S El-Kamary; Jon P Furuno; Ram R Miller; Eli N Perencevich
Journal: Clin Infect Dis Date: 2007-08-23 Impact factor: 9.079

4. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.

Authors: David M Livermore; Shazad Mushtaq; Marina Warner
Journal: J Antimicrob Chemother Date: 2005-02-10 Impact factor: 5.790

5. Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa.

Authors: Ellie J C Goldstein; Diane M Citron; Victoria Peraino; Tanya Elgourt; Anne R Meibohm; Shuang Lu
Journal: Antimicrob Agents Chemother Date: 2009-09-28 Impact factor: 5.191

Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?

1. Segmented regression analysis of interrupted time series studies in medication use research.

2. Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit.

3. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies.

4. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.

5. Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa.

6. Methods for estimating confidence intervals in interrupted time series analyses of health interventions.

7. Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem.

8. The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.